Harm Reduction Symposium | #ACMT2025 | On-Demand

Harm Reduction Symposium | #ACMT2025 | On-Demand

  • Register
    • Non-member - Tier I - $400
    • Non-member - Tier II - $300
    • Non-member - Tier III - $225
    • Non-member - Tier IV - $200
    • Member - Tier I - $250
    • Member - Tier II - $200
    • Member - Tier III - $125
    • Member - Tier IV - $75

2025 ACMT Symposium | Harm Reduction in the Management of SUD

On-Demand

Harm reduction is a critical yet often misunderstood component in the care of patients with substance use disorders (SUD). Encompassing tools such as needle exchange programs, naloxone distribution, supervised consumption sites, and fentanyl test strips, harm reduction strategies vary widely in their implementation and effectiveness. While some, like needle exchanges, have well-documented public health benefits, others are more difficult to measure—and their adoption varies across clinical settings and communities.

Originally held in Vancouver, Canada—a global leader in harm reduction—this in-person symposium took a deep dive into the evolving landscape of harm reduction in SUD care. Now available on-demand, the course includes 7 asynchronous lectures that explore evidence-based approaches across the continuum of care and the healthcare system.

Topics include:

  • Integrating harm reduction with medications for opioid use disorder

  • Implementing substance use education in clinical practice

  • Inpatient high-dose methadone titration protocols

  • A panel on “Lived Experience” featuring real-world perspectives from people with direct experience navigating recovery and harm reduction

Designed for professionals in emergency medicine, family medicine, addiction medicine, medical toxicology, and related fields, this activity provides valuable insights into the practical, ethical, and systemic considerations surrounding harm reduction.


Learner Objectives

Learners should be able to:

  • Analyze the evidence surrounding various harm reduction strategies in the management of substance use disorders, with a focus on their effectiveness across different settings and populations.

  • Evaluate the role of harm reduction tools at different stages of the recovery process and identify how they can be integrated with other treatment modalities to optimize patient outcomes.

  • Discuss the ethical and practical considerations of harm reduction practices, including the perspectives of healthcare providers, patients, and the broader recovery community.


image

Continuing Education

Continuing Education credit for this activity is included in the registration fee. Accreditation is provided by AKH Inc., Advancing Knowledge in Healthcare, and registrants will be able to claim up 6.25 enduring activity credits. Continuing Education credits are available for Physicians (CME), Pharmacists (CPE) and Nurses (CNE).


Questions?

Please write to ACMT at events@acmt.net

Registration Rates

Registration includes:

  • 90-day access to recordings of the live event


  • Access to the speaker slides


  • 6.25 Continuing Education Certificate available for Physicians, Nurses, and Pharmacists.

Member Rates


     Member Tier I: Full, Affiliate, International, Emeritus


     $300


     Member Tier II: Fellows


     $250


     Member Tier III: Residents, International - Developing Country


     $175


     Member IV: Medical Students


     $150

Non-Member Rates


     Non-member Tier I: Physicians, Pharmacists, Lawyers, "Other"


     $300


     Non-member Tier II: Fellows, SPIs, Nurses, etc.


     $250


     Non-member Tier III: Educators & Emergency Responders


     $175


     Non-member IV: Residents & Students


     $150


ACMT Membership

ACMT Members receive a discounted rate. Interested in becoming an ACMT Member? Contact our Membership Team at membership@acmt.net. Learn more at: www.acmt.net/membership


Refunds and Cancellations

For information on ACMT's Cancellation and refund policy, click here.


Questions?

For any questions, please email us at events@acmt.net.

Instructions

Once you have completed your registration:

  1. Click on the Contents tab. This is where you will be able to see all lectures and required content for this course.
  2. Watch all lectures. Learners will be required to watch at least 3/4 of the video before it will be marked as complete.
  3. Complete the Post-Test. These questions are based on content from the lectures and require a 70% to pass.
  4. Complete the CE Survey. These questions are required to claim your CE certificate.
  5. Once you have completed all other components, you will be able to claim your CE certificate.

Hardware/Software Requirements

Computer or Other Internet-Enabled Device; Internet Connection; Browser. 

Materials

None. 

Prerequisites

None.

Format

This is a self-guided course with CME, CNE, and CPE.


Need Assistance or Have Questions?

For assistance logging in, accessing content, purchasing or completing Continuing Education credits, or for other questions, please contact us at events@acmt.net or visit our FAQ page.

If you are in need of accessible learning accommodations, please contact events@acmt.net for additional assistance.

Syllabus



Donovan Lecture | On the Streets with Evolving Polysubstance Use — The Rise of 'Fentanyl-Plus' and Its Impact on Mortality, Morbidity, and Harm Reduction

Daniel Ciccarone, MD MPH, Justine Miner Professor of Addiction Medicine, Family and Community Medicine, UCSF, San Francisco, CA

This lectureship is supported by the Medical Toxicology Foundation through the Ward and Ryan Donovan Memorial Fund. For more info, please visit: www.acmt.net/donovan-lectureship.


Politics and History of Harm Reduction in Vancouver, Successes & Challenges

Patricia Daly, MD, Chief Medical Health Officer, Vancouver Coastal Health; Clinical Professor, School of Population and Public Health, Faculty of Medicine at the University of British Columbia, Vancouver, Canada


Voices of Experience: A Discussion on Living and Practicing Harm Reduction

Moderator: Leslie Dye, MD FACMT FASAM, Medical Director, OneFifteen; Clinical Professor, Department of Emergency Medicine, Boonshoft School of Medicine, Wright State University, Dayton, OH

Panelists:
Daniel Ciccarone, MD MPH, Justine Miner Professor of Addiction Medicine, Family and Community Medicine, UCSF, San Francisco, CA
Patricia Daly, MD, Chief Medical Health Officer, Vancouver Coastal Health; Clinical Professor, School of Population and Public Health, Faculty of Medicine at the University of British Columbia, Vancouver, Canada
Guy Felicella, International Public Speaker, Drug Policy Advocate, Vancouver


Integrating Harm Reduction with Prevention, Treatment, and Personal Accountability: Saving Lives Without Creating Pill Mills 2.0

Leslie Dye, MD FACMT FASAM, Medical Director, OneFifteen; Clinical Professor, Department of Emergency Medicine, Boonshoft School of Medicine, Wright State University, Dayton, OH


Rapid Inpatient Methadone Initiations in the Fentanyl Era

Robert Cole Pueringer, MD, Medical Toxicologist and Addiction Medicine Specialist, Essentia Health, Duluth, MN


Integrating Harm Reduction Approaches in Hospital Care: Inpatient Substance Use Policies

Moderator: Anthony Spadaro, MD, Fellow-in-Training, Rutgers New Jersey Medical School, Rutgers, NJ

Panelists:
Gillian Beauchamp, MD, FACMT, FASAM, Program Director, Medical Toxicology Fellowship; Associate Professor, Lehigh Valley Health Network; USF Morsani College of Medicine, Allentown, PA
Evan Schwarz, MD, FACMT, Associate Professor of Emergency Medicine, University of California, Los Angeles, CA


Timing is Everything: Harm Reduction for Special Populations — An Interactive Case-Based Discussion of Who, When, and Where

Moderator: Ashley Haynes, MD FACEP, Medical Toxicologist, Addiction Medicine Specialist, Veterans Health Administration, Andover, KS

Panelists:
JoAn Laes, MD, FACMT, FASAM, Abbott Northwestern Hospital, Allina Health, Minneapolis, MN
Timothy J. Wiegand, MD FACMT DFASAM, Director of Toxicology and of the Toxicology Consult Service, University of Rochester Medical Center, Rochester, NY

Daniel Ciccarone, MD, MPH

Justine Miner Professor of Addiction Medicine

University of California, San Francisco

Dr. Dan Ciccarone is the Justine Miner Professor in Addiction Medicine in the Department of Family and Community Medicine at UCSF. He has been the principal or co-investigator on numerous NIH-sponsored public health research projects, including his current Synthetics in Combination (SYNC) study. He is a recognized international scholar on the medical, public health, and public policy dimensions of substance use, risk, and consequences. He consults for numerous private and public entities, including the Office of National Drug Control Policy (ONDCP), the US Centers for Disease Control and Prevention (CDC), and the US Food and Drug Administration (FDA). For over 20 years "Dr. Dan" has been actively involved in expanding the use of clinical harm reduction technologies and services, e.g., naloxone, buprenorphine, and drug checking. He has provided harm reduction-based clinical services at several SF syringe exchanges and is currently the volunteer Medical Director of Remedy Alliance, the US’ largest not-for-profit wholesale distributor of naloxone.

Patricia Daly, MD

Chief Medical Health Officer, Vancouver Coastal Health;

Clinical Professor, School of Population and Public Health, Faculty of Medicine, University of British Columbia

Dr. Patricia Daly is the Vice President, Public Health and Chief Medical Health Officer for Vancouver Coastal Health and a Clinical Professor in the School of Population and Public Health at the University of British Columbia. As a public health physician, she focuses on improving population health through prevention, health promotion, communicable disease control, environmental health, and public health surveillance. Dr. Daly earned her medical degree from the University of Toronto in 1985 and worked as a family and emergency physician before completing specialty training at McGill University and the University of Toronto, earning a fellowship in Community Medicine in 1992. After moving to Vancouver in 1993, she served at the BC Centre for Disease Control and later at the Vancouver/Richmond Health Board. Since the formation of Vancouver Coastal Health in 2001, she has continued to lead communicable disease control efforts, assuming her current role in 2007. In addition to her leadership duties, Dr. Daly consults with health professionals, advises the public on key health issues, and teaches medical students and residents at UBC.

Gillian Beauchamp, MD, FACMT, FASAM

Vice Chair, Education & Community Engagement

Lehigh Valley Health Network, USF Morsani College of Medicine, Jefferson Health

Gillian Beauchamp, MD, is Vice Chair for Education and Community Engagement in the Lehigh Valley Health Network Department of Emergency and Hospital Medicine & Division of Medical Toxicology. She is an Associate Professor at USF Morsani College of Medicine, and Adjunct Clinical Associate Professor at Jefferson University. She is board certified in Emergency Medicine, Medical Toxicology and Addiction Medicine. She is an Editorial board member for Toxicology Communications and a Reviews Section Editor and Editorial board member for the Journal of Medical Toxicology; and is co-host for the Tox in Ten: ACMT Highlights podcast.

Leslie R. Dye, MD FACMT FASAM

Medical Director, OneFifteen

Clinical Professor, Department of Emergency Medicine, Boonshoft School of Medicine, Wright State University

Leslie R. Dye, MD is triple board certified in emergency medicine, medical toxicology, and addiction medicine. She has worked in the fields of medical toxicology and addiction medicine for 30 years. In addition to her clinical expertise, she has academic and business content expertise from experiences as an editor-in-chief (EIC) of a peer-reviewed medical journal (Journal of Medical Toxicology) and EIC of physician and pharmacist content production for a leading international medical digital content provider. Her deep subject matter expertise is demonstrated in her role as senior editor of the textbook, Case Studies in Medical Toxicology, author of 18 peer reviewed publications and 16 textbook chapters, 66 national and 11 international presentations, 10 various commentaries, interviews, and podcasts. Her leadership skills have been proven in both corporate and academic environments, as professor at a medical school, long-term board member and past president of the American College of Medical Toxicology, Chair of the Addiction Medicine Committee, former co-chair, and co-moderator of the AACT Acute and Intensive Care Symposium, and as the manager of as many as 30 team members at an international corporation. She received a funded grant that enabled her to start the first poison control center in mainland China and trained 6 Chinese physicians in the field of medical toxicology over 3 years in the US. Dr. Dye is experienced in and continues to provide medical care in remote polar regions with no access to advanced medical facilities.

Ashley Haynes, MD, FACEP

Medical Toxicologist, Addiction Medicine Specialist

Veterans Health Administration

Dr. Haynes completed training in a combined emergency medicine-internal medicine program in 2014, and a toxicology fellowship at UTSW in 2016. She has been treating substance use disorders as part of her practice since that time and is board certified in addition medicine. She currently works for the VA at the Robert J Dole Veterans Medical Center in Wichita, KS, treating patients in a residential treatment center, as well as clinic, and performing bedside consults.

JoAn Laes, MD, DFASAM, FACMT

Addiction Staff Physician

Abbott Northwestern Hospital, Allina Health

JoAn Laes, MD, DFASAM, FACMT is an addiction medicine physician in Minneapolis, Minnesota, focusing on inpatient addiction medicine and toxicology consultation as well as experience in outpatient treatment of opioid and other substance use disorders. She is also a core medical toxicology faculty for the Minnesota Poison Center, Minneapolis, Minnesota, and medical director for Missions Inc. Detox facility in Plymouth, Minnesota. She is board certified in Internal Medicine, Medical Toxicology, and Addiction Medicine. She completed internal medicine residency at Hennepin County Medical Center and medical toxicology fellowship at Regions Hospital in St. Paul, Minnesota.

Robert "Cole" Pueringer, MD

Medical Toxicologist, Addiction Medicine Specialist, Hospitalist

Essentia Health in Duluth

Dr. Robert “Cole” Pueringer is a Medical Toxicologist, Addiction Medicine Specialist, and Hospitalist. He joined Essentia Health in September of 2022. He completed his medical training in the Twin Cities, including Medical School at the University of Minnesota, Internal Medicine Residency and Chief Resident year at Hennepin County Medical Center (HCMC). He received his CTropMed certification for Tropical Medicine & Travelers’ Health at the University of Minnesota. He then completed a Medical Toxicology fellowship at the Health Partners Institute/HCMC in 2021 and an Addiction Medicine fellowship at the University of Minnesota in 2022. His academic interests include medical education, Global Health, and the overlap of Medical Toxicology and Addiction Medicine. He is particularly passionate about substance use disorder - a disease that has affected many aspects of his own life – and hopes to contribute significantly to substance use treatment, education, de-stigmatization, and harm reduction in northern Minnesota.

Evan Schwarz, MD, FACMT

Associate Professor of Emergency Medicine

University of California, Los Angeles

Dr. Schwarz attended medical school at the University of Texas Medical Branch in Galveston, Texas, before completing a residency in Emergency Medicine at the Washington University School of Medicine in Saint Louis, Missouri.  After residency, he completed a fellowship in Medical Toxicology at the University of Texas Southwestern School of Medicine in Dallas, Texas, before returning to Missouri where he was an Advisory Dean and the Medical Toxicology Division Chief and Fellowship Director at Washington University. In 2023, he took a position in the Department of Emergency Medicine at the University of California Los Angeles. He is also a member of the Board of Directors for ACMT.

Anthony Spadaro, MD

Fellow-in-Training

Rutgers New Jersey Medical School

Anthony Spadaro attended the University of Pennsylvania where he completed his MD and MPH. He then completed his residency in Emergency Medicine at the Hospital of the University of Pennsylvania. As a resident, his research interests included naloxone distribution in the ED, the impacts of fentanyl on precipitated withdrawl, and emerging novel psychoactives in the drug supply such as xylazine. He is also interested in harm reduction and social emergency medicine. In his free time, he enjoys running long distances, walking his dog, and watching Star Trek.

Timothy Wiegand, MD, DFASAM, FACMT, FAACT

Director of Addiction Medicine and Addiction Medicine Consults, University of Rochester Medical Center

ASAM President Elect (2025-2027)

Dr. Tim Wiegand is an Associate Professor of Emergency Medicine and Public Health Sciences at the University of Rochester Medical Center (URMC) in Rochester, New York. Board-certified in both Medical Toxicology and Addiction Medicine, Dr. Wiegand specializes in Addiction Toxicology, combining clinical practice with research, teaching, and leadership roles. He has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and is currently on the Board of Directors for the American Society of Addiction Medicine (ASAM). From 2023-2025, he served as Treasurer of ASAM, having previously served as Vice President on the Executive Council. From 2025-2027, Dr. Wiegand will serve as ASAM President Elect and then ASAM President (2027-2029). Dr. Wiegand founded and led the Toxicology Service at URMC until 2022, when he transitioned to Director of Addiction Medicine and Director of Addiction Medicine Consults in the Department of Emergency Medicine. He also serves as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and is leading efforts to launch the URMC Medical Toxicology Fellowship, which is expected to be formally accredited by July 2023.

Key:

Complete
Failed
Available
Locked
Donovan Lecture | On the Streets with Evolving Polysubstance Use — The Rise of 'Fentanyl-Plus' and Its Impact on Mortality, Morbidity, and Harm Reduction
Recorded 04/03/2025  |  57 minutes
Recorded 04/03/2025  |  57 minutes Daniel Ciccarone, MD, MPH, Justine Miner Professor of Addiction Medicine, Family and Community Medicine, UCSF, San Francisco, CA
Politics and History of Harm Reduction in Vancouver, Successes & Challenges
Recorded 04/03/2025  |  61 minutes
Recorded 04/03/2025  |  61 minutes Patricia Daly, MD, Chief Medical Health Officer, Vancouver Coastal Health; Clinical Professor, School of Population and Public Health, Faculty of Medicine at the University of British Columbia, Vancouver, Canada
Voices of Experience: A Discussion on Living and Practicing Harm Reduction
Recorded 04/03/2025  |  32 minutes
Recorded 04/03/2025  |  32 minutes Leslie Dye, MD FACMT FASAM, Medical Director, OneFifteen; Clinical Professor, Department of Emergency Medicine, Boonshoft School of Medicine, Wright State University, Dayton, OH; Daniel Ciccarone, MD MPH, Justine Miner Professor of Addiction Medicine, Family and Community Medicine, UCSF, San Francisco, CA; Patricia Daly, MD, Chief Medical Health Officer, Vancouver Coastal Health; Clinical Professor, School of Population and Public Health, Faculty of Medicine at the University of British Columbia, Vancouver, Canada; Guy Felicella, International Public Speaker, Drug Policy Advocate, Vancouver
Integrating Harm Reduction with Prevention, Treatment, and Personal Accountability: Saving Lives Without Creating Pill Mills 2.0
Recorded 04/03/2025  |  51 minutes
Recorded 04/03/2025  |  51 minutes Leslie Dye, MD FACMT FASAM, Medical Director, OneFifteen; Clinical Professor, Department of Emergency Medicine, Boonshoft School of Medicine, Wright State University, Dayton, OH
Rapid Inpatient Methadone Initiations in the Fentanyl Era
Recorded 04/03/2025  |  34 minutes
Recorded 04/03/2025  |  34 minutes Robert Cole Pueringer, MD, Medical Toxicologist and Addiction Medicine Specialist, Essentia Health, Duluth, MN
Integrating Harm Reduction Approaches in Hospital Care: Inpatient Substance Use Policies
Recorded 04/03/2025  |  45 minutes
Recorded 04/03/2025  |  45 minutes Anthony Spadaro, MD, Fellow-in-Training, Rutgers New Jersey Medical School, Rutgers, NJ; Gillian Beauchamp, MD, FACMT, FASAM, Program Director, Medical Toxicology Fellowship; Associate Professor, Lehigh Valley Health Network; USF Morsani College of Medicine, Allentown, PA; Evan Schwarz, MD, FACMT, Associate Professor of Emergency Medicine, University of California, Los Angeles, CA
Timing is Everything: Harm Reduction for Special Populations — An Interactive Case-Based Discussion of Who, When, and Where
Recorded 04/03/2025  |  45 minutes
Recorded 04/03/2025  |  45 minutes Ashley Haynes, MD FACEP, Medical Toxicologist, Addiction Medicine Specialist, Veterans Health Administration, Andover, KS; JoAn Laes, MD, FACMT, FASAM, Abbott Northwestern Hospital, Allina Health, Minneapolis, MN; Timothy J. Wiegand, MD FACMT DFASAM, Director of Toxicology and of the Toxicology Consult Service, University of Rochester Medical Center, Rochester, NY
Post-Test
9 Questions  |  Unlimited attempts  |  7/9 points to pass  |  Graded as Pass/Fail
9 Questions  |  Unlimited attempts  |  7/9 points to pass  |  Graded as Pass/Fail This test requires a 70% to pass. You have unlimited attempts.
CE Survey
22 Questions
22 Questions Please complete this survey to access your CE Certificate.
CE Certificate
Up to 6.25 medical credits available  |  Certificate available
Up to 6.25 medical credits available  |  Certificate available